The aim of this study was to assess the effectiveness of bispectral index monitoring (BIS) as a guide to the timing of intubation during sevoflurane induction of anaesthesia without the use of neuromuscular blocking agents in adults, and specifically, whether a target BIS value of 25 provides better intubating conditions than a target BIS of 40.
Inhalational induction of anaesthesia with sevo flurane is a well-established, well-documented, effective and safe technique 14 .
There are many advocates of inhalational induction of anaesthesia, as it allows a rapid induction and a smooth transition to maintenance of anaesthesia 59 . One of the main benefits of inhalational induction of anaesthesia in adults is its use in patients with predicted difficult airway management, as the anaesthetist can maintain a spontaneously ventilating patient and avoid the use of neuromuscular blockade 4, 10 .
The clinical timing as to when to intubate during an inhalational induction without the use of neuromuscular blockade can pose a problem for anaesthetists. If the depth of anaesthesia is insufficient, intubation may evoke unwanted airway reflexes and sympathetic stimulation, and there may be a risk of awareness. If the anaesthetic depth is excessive, the patient may experience haemodynamic instability and other unwanted side-effects.
End-tidal concentration of sevoflurane (E T Sevo) has been used to determine the most appropriate time to intubate during inhalational induction 2 . In a study of 86 patients, Kimura et al 2 showed an E T Sevo of 4.5% maintained for 20 minutes (CI 3.9-5.2%) as appropriate to allow reasonable intubating conditions without unwanted airway reflexes.
Although E T Sevo is a suitable indicator to predict timing of intubation, several issues arise. First, there is a wide patient variability as demonstrated by the confidence interval range in Kimura et al 2 of 3.9% to 5.2%. Also the use of premedication can have a variable effect on the concentration of sevoflurane required to allow intubation 1 .
The use of BIS monitoring is well justified in anaesthetic management as it has been shown to correlate with depth of anaesthesia [11] [12] [13] and to reduce the incidence of patient awareness 14 . However, no previous study has investigated the use of BIS monitoring to predict the suitable timing of intubation during inhalational induction in adults (based on a literature search of OVID-Medline and PubMed databases). BIS monitoring was used as a guide of depth of anaesthesia but not to guide intubation in a study by Weber et al 15 , which compared intubating conditions with and without remifentanil in paediatric patients.
It is possible that the use of BIS monitoring may prove to be an appropriate guide to predict the suitable timing of intubation in adults. The postulated advantages of BIS monitoring over E T Sevo to predict the optimum timing of intubation are twofold. First, it should account for the variable effect of premedication. Second, it may overcome patient variability in regard to the relationship between E T Sevo and the pharmacodynamic effects of sevoflurane, as BIS directly assesses the 'depth of anaesthesia' 11-13 based on information from the brain.
The hypothesis for this study is that the use of BIS monitoring to guide the timing of intubation during sevoflurane induction provides adequate intubating conditions and reduces the incidence of unwanted side-effects. More specifically, the primary aim was to assess and compare intubating conditions at a BIS value of 25 vs a BIS value of 40. The primary outcome variable for this study, therefore, was ease of intubation as determined by the total intubation score. Secondary aims were to compare the haemodynamic profile and the incidence of unwanted side-effects experienced at each of these target BIS values.
In designing this study, a tidal volume induction with sevoflurane was chosen, as a study conducted by yogengran et al 3 comparing different methods of sevoflurane induction of anaesthesia in 124 patients demonstrated no significant difference in induction times between a vital capacity breath induction vs tidal volume induction.
The decision to premedicate patients with midazolam and fentanyl was based on a study conducted by Muzi et al 1 investigating the effect of premedication on induction of anaesthesia with sevoflurane. This study demonstrated the use of midazolam 9 µg/kg and fentanyl 0.6 µg/kg in reducing the time to obtain suitable intubating conditions during inhalational induction by a mean of 2.5 minutes.
MATERIALS AND METHODS
Approval to conduct the study was obtained from the local Human Research Ethics Committee (HREC-Gold Coast Health District).
Participants who met all of the following criteria were eligible for inclusion in the study: surgical patients requiring general anaesthesia with tracheal intubation; ability to give informed consent; ASA Physical Status I-II classification, age 18 to 55 years, Body Mass Index (BMI) less than 30 kg/m 2 ; no contraindication to inhalational induction (e.g. fasted for less than six hours; history of gastro-oesophageal reflux or hiatus hernia; airway anatomy not conducive to bag/mask ventilation).
Exclusion criteria were: patients not able to give informed written consent (e.g. mental impairment, language difficulties or poor comprehension of English); pregnancy; a significant history of heart disease or cerebrovascular disease; a history of asthma, recent respiratory tract infection or moderate to severe chronic obstructive airways disease; a recent history of alcohol or substance abuse; previous or predicted difficult intubation (as assessed using standard criteria, e.g. Cormack & Lehane Grade 2b or greater, Mallampati grade 3 or greater or a thyromental distance less than three finger breadths).
A total of 40 patients were recruited to take part in the study. This decision was based on a two-tailed power analysis, in accordance with a Mann-Whitney u test, to determine the sample size required to obtain a statistically significant result (P=0.05 and power 80%). Computation was based on a mean difference in intubating scores of 1.5, and a common within-group standard deviation of 1.6, as extrapolated from data of intubation scores of 60 patients in the sevoflurane nitrous oxide arm of the study conducted by Iamaroon et al 9 . An effect size of 1.5 was selected as the smallest effect that would be important to detect, in the sense that any smaller effect would not be of clinical or substantive relevance.
Randomization was assigned by a computergenerated sequence randomly allocating a study group, BIS 25 or BIS 40, to each research number, thereby giving each participant an equal chance of being allocated to either group. The assigned randomized group details were placed in a sealed opaque envelope, to be seen only by the supervising anaesthetist. The patient and intubating anaesthetist were blinded to the allocated group.
Written informed consent was obtained from all participants. Patients underwent routine preoperative assessment by an anaesthetist and were informed of relevant details of the anaesthetic procedure to be received. Baseline demographic details of each participant were recorded, including age, gender, ASA physical status, co-existing disease and type of surgery.
On arrival to the anaesthetic room the patient was assigned to a research number with the accompanying sealed envelope containing the randomized allocated group. Once intravenous access was established, patients received intravenous premedication of midazolam 20 µg/kg and fentanyl 0.5 µg/kg five minutes before preoxygenation and commencement of induction.
All patients received standard anaesthetic monitoring including pulse oximetry, non-invasive blood pressure, electrocardiograph, end-tidal CO 2 , fraction of inspired O 2 , E T Sevo concentration and bispectral monitoring (BIS-XP integrated module for Datex monitor, version 4.0, Aspect Medical Systems Inc., Newton MA, u.S.A.). For BIS monitoring, the skin of the forehead was cleaned with an alcohol swab and dried with gauze before the application of a BIS-quatro sensor strip in accordance with the manufacturer's instructions. One-minutely observations were recorded from the time of commencing induction of anaesthesia until five minutes post intubation. Observations were then taken 2.5 to 5 minutely thereafter. A standard stopwatch was used to calculate time to reach target BIS value and time to intubation.
Two anaesthetists were involved during induction of anaesthesia. A supervising anaesthetist would open the allocated envelope, commence induction with sevoflurane at 6 to 8% with a gas flow rate of 6 l/min O 2 and titrate the inspired concentration of sevoflurane to achieve the allocated target BIS value. Once the target BIS value was achieved, the supervising anaesthetist would maintain the target BIS (±5) for two minutes and then instruct the intubating anaesthetist to commence intubation. If, however, the target BIS value could not be achieved after a time period of ten minutes, the supervising anaesthetist would instruct the intubating anaesthetist to proceed.
The intubating anaesthetist was blinded to the allocated target BIS and was unable to view the anaesthetic monitoring. The role of the intubating anaesthetist was to commence pre-oxygenation, maintain the patient's airway with bag and mask, to commence laryngoscopy and intubation once instructed, and to rate the intubating conditions on completion using the standardized table seen in Table 1 (adapted from intubation scoring tables used by Iamaroon et al 9 and Weber et al 15 ). The investi gator of this project (third year anaesthetic training registrar) was the intubating anaesthetist for all patients in the study to provide consistency in intubating scores.
Details of any complications, failed intubation on first attempt or any other relevant details were recorded on the data sheets. If intubation was unsuccessful on first attempt a decision was made between the anaesthetists to either have a second attempt under sevoflurane anaesthesia or to use adjuvants to facilitate successful intubation (i.e. propofol, opioids or neuromuscular blocking agents). The intubation score was based on conditions experienced on the first attempt at laryngoscopy.
The anaesthetic management of each patient was then completed according to standard practice.
A postoperative follow-up interview of patients was conducted in the weeks following participation to assess any postoperative complications such as nausea/vomiting and awareness, and to ascertain patient satisfaction.
Data was analysed using SPSS version 14.0 for Windows (SPSS Inc., Chicago, IL, u.S.A.), under the direction of a statistician. For ordinal data (intubation scores), groups were compared using the Mann Whitney u-test; for continuous data, groups were tested for normal distribution using the Kolmogorov-Smirnov test, then compared using a two-tailed, twosample t-test; and for categorical data, groups were compared using the chi-square test or Fishers exact test as appropriate. The log rank test followed by the chi-square test was used to compare groups with regard to time taken to achieve target BIS and time to intubation. P<0.05 was considered statistically significant. (2) tight but opens (3) impossible (4) Vocal cords wide open (1) mid position (2) moving (3) closed (4) Reaction to intubation none (1) diaphagmatic movement or short lived cough (2) mild/moderate cough (3) severe cough (4) Overall score 3-4=excellent 5-6=good 8-12=poor / impossible RESuLTS Forty patients were recruited into the study, with 21 patients randomized into the BIS 25 group and 19 patients into the BIS 40 group.
The demographic profiles of the groups were statistically similar with respect to age, gender, BMI and ASA physical status ( Table 2 ). this category. In the BIS 40 group, although the jaw was often adequately relaxed with 18 of 19 patients scoring 1 or 2, the vocal cord position was variable and the response to intubation often resulted in more severe coughing or movement, with 18 of 19 scoring 2 or more in this category, and with 12 patients scoring 4 for response to intubation. Table 4 shows the details of the actual BIS achieved, the maximal BIS value post intubation, the time to achieve the target BIS value, and the E T Sevo concentrations upon reaching the target BIS and upon intubation. This shows that the actual BIS value achieved was on average a little higher than 25 in the BIS 25 group, and a little lower than 40 in the BIS 40 group, giving an actual BIS value difference between groups of approximately 10. The intubation rating scores demonstrated superior intubating conditions at a target BIS 25 versus target BIS 40 (P<0.001). The median intubating score for the BIS 25 group was 4 (range 3-9, [IQR 4-5]) vs the BIS 40 group with a median of 7 (range 5-10, IQR 6-9) ( Table 3) .
Analysing the intubating scores demonstrated that there was good jaw relaxation and open vocal cord position obtained at a BIS target of 25. In this group, 19 of 21 patients scored 1 for jaw relaxation and 20 of 21 scored 1 or 2 for vocal cord position. Response to intubation, however, was not ideal in the BIS 25 group, with 17 of 21 patients scoring 2 or more for The time to reach target BIS values was not statistically different (BIS 25 group 6.6 min, BIS 40 group 5.1 min, P=0.054).
The maximal BIS post intubation in the 25 group was on average 52±17 versus the 40 group 64±15. This was a statistically significant difference (P<0.025).
The oxygenation and haemodynamic parameters were similar between the two groups ( Tables 5 and 6 ). There was no increase in haemodynamic instability in the BIS 25 group, nor was there any requirement for atropine or vasopressors in either group. There was no incidence of laryngospasm in either group.
There were six cases (31.5%) of failure to intubate on the first attempt in the BIS 40 group vs only one case of failed intubation on first attempt in the 25 group (4.8%).
Of the 40 patients, 31 were able to be contacted for follow-up interview following participation in the study, 16 from the BIS 25 group and 15 from the BIS 40 group. Patient satisfaction was high in both groups with only one patient reporting poor satisfaction with the procedure due to prolonged nausea for eight to ten hours.
Among the BIS 25 group respondents, satisfaction was rated excellent by four patients (25%) and good by the remaining 12 patients (75%). Amongst the BIS 40 group, satisfaction was rated excellent by three patients (20%), good by 11 patients (73%) and poor in only one patient (7%). In regard to sideeffects reported, three patients (19%) of the BIS 25 group complained of postoperative nausea or vomiting compared to two patients (13%) in the BIS 40 group, P=0.99. Sore throat was experienced by two patients (12.5%) in the BIS 25 group compared with three patients (20%) in the 40 group, P=0.65. Of the other side-effects reported, one respondent in the BIS 25 group complained of urinary retention and one respondent in the BIS 40 group complained of 'the shakes' postoperatively. There was no case of awareness reported in either group.
DISCuSSION
The primary aim of this study was to assess and compare intubating conditions using a target BIS 25 vs a target BIS 40 as a guide to timing of intubation during sevoflurane induction of anaesthesia. A BIS of 25 clearly provided adequate intubating conditions to allow successful intubation without increasing the incidence of haemodynamic instability or side-effects. A BIS of 40 was clearly inadequate at providing suitable intubating conditions, with a 31.5% failure rate on first attempt at intubation.
There may be a few reasons why a target BIS 25 provided significantly better intubating conditions. First, the greater depth of anaesthesia at BIS 25 may provide greater relaxation of jaw muscles and may obtund airway reflexes to a greater degree. Another possible reason for the difference between the two groups may relate to the greater time taken to commence intubation. The longer induction time may allow greater absorption of sevoflurane into the effect site tissues (brain, spinal cord) and therefore obtund airway reflexes to a greater degree. This longer time for effect may also apply to the fentanyl and midazolam premedication given. This is however, unlikely to solely account for the large difference between groups given the small doses used.
The mean E T Sevo at the time of reaching the target BIS 25 and at the time of intubation was 5.3% and 5.2% respectively. This value is slightly higher than the 4.5% predicted by Kimura et al 2 to provide adequate intubating conditions. This difference can be accounted for by the fact that in Kimura and colleagues' study, patients were maintained at this E T Sevo concentration for 20 minutes to allow for equilibrium. In the current study, the average time to intubation was 8.6 minutes, allowing less time for equilibrium, and therefore a higher E T Sevo concentration would be expected to provide a similar effect. This would suggest that BIS may be a more useful guide for intubation as there is less need to wait for a theoretical equilibrium before commencing intubation.
The results seen in the BIS 25 group of this study are similar to those seen in the sevoflurane-nitrous oxide group of the study by Iamaroon et al 9 . The Iamaroon et al study compared intubating conditions in 120 patients using sevoflurane-nitrous oxide versus thiopentone-suxamethonium induction. The patients in the sevoflurane-nitrous oxide group were induced with 8% sevoflurane and 66% nitrous oxide until loss of eyelash reflex, and ventilation was assisted until an E T Sevo of approximately 6% was reached before intubation was commenced. Comparing the results from these patients with those from the BIS 25 group shows similar intubating conditions with regard to jaw relaxation, vocal cord position and overall intubating score; however, response to intubation was higher in the BIS 25 group. This suggests little difference between the use of BIS or E T Sevo as a guide to intubation. The benefits of BIS over E T Sevo are, however, likely to been seen in patients with less functional reserve, such as the elderly or patients with significant co-morbidities. These patients are more likely to experience haemodynamic instability with increasing sevoflurane concentrations; therefore targeting E T Sevo values of 4.5% are likely to cause significant side-effects. The BIS values however, should correlate with the end-organ effect of sevoflurane at the brain site, providing a more appropriate guide to the time to commence intubation once an adequate depth of anaesthesia has been achieved.
There may be some problems with using BIS 25 as a guide to intubation. Although good jaw relaxation and vocal cord position were encountered, at least some response to intubation was experienced in most patients. This was most commonly noted after cuff inflation. Possible solutions to reducing this response to intubation while maintaining a spontaneously ventilating patient and avoiding the use of neuromuscular blockers could be to spray the vocal cords with local anaesthetic, to use a higher or repeat dose of opioid or maintain the target BIS value for a longer period before intubation or to target a lower BIS value. The benefits and side-effects of each of these techniques would need to be considered and studied to ascertain their ability to reduce patient response to intubation.
Other problems with using a target BIS 25 to guide timing of intubation may also be encountered. First, the induction to intubation times can be relatively long. Induction to intubation times on average were 8.6 minutes in the BIS 25 group. Second, a BIS 25 may not always be able to be achieved. In 6 of the 21 patients the target BIS of 25 could not be achieved and intubation proceeded after the allocated 10 minutes. Despite being unable to reach the target BIS, adequate intubating conditions were experienced to allow successful intubation in all of these patients.
Both of the above problems might be alleviated by the use of a 12% sevoflurane vaporizer. A study by Goodwin et al 16 demonstrated faster induction times with a 12% sevoflurane vaporizer in comparison to the standard 8% vaporizer, with no difference in haemodynamic profiles or respiratory complications between groups.
Overall, this study demonstrates the merits of BIS monitoring as a useful tool in guiding the timing of intubation during sevoflurane induction of anaesthesia without neuromuscular blockade. The results suggest that targeting a BIS of 25 should provide adequate intubating conditions without increasing the risk of unwanted sideeffects.
